Bristol-Myers Squibb Company (FRA:BRM)
39.91
-0.09 (-0.23%)
At close: Jun 27, 2025, 10:00 PM CET
Bristol-Myers Squibb Company Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€1,292,458
Profits / Employee
€147,028
Market Cap
80.51B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Rheinmetall AG | 28,539 |
Siemens Energy AG | 98,000 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Siemens Healthineers AG | 72,000 |
Bristol-Myers Squibb Company News
- 4 days ago - Cigna sues Bristol Myers for alleged monopoly over blockbuster cancer drug - CNBC
- 4 days ago - Cigna files antitrust case against Bristol Myers over Pomalyst sales - Seeking Alpha
- 11 days ago - Bristol Myers Squibb Announces Dividend - Wallstreet:Online
- 12 days ago - Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi (lisocabtagene maraleucel) - Wallstreet:Online
- 16 days ago - Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD Agents and BCL6 Ligand-Directed Degrader at EHA 2025 - Wallstreet:Online
- 17 days ago - Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 17 days ago - Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis - Wallstreet:Online
- 20 days ago - Notable healthcare headlines for the week: Bristol Myers Squibb, Novo Nordisk and Sanofi in focus - Seeking Alpha